February 15, 2018 / 1:55 PM / 7 months ago

BRIEF-Knight Therapeutics Says New Drug Submission For Netildex Accepted For Review By Health Canada​

Feb 15 (Reuters) - Knight Therapeutics Inc:

* KNIGHT THERAPEUTICS AND SIFI S.P.A. ANNOUNCE FILING OF NEW DRUG SUBMISSION FOR NETILDEX IN CANADA

* KNIGHT THERAPEUTICS INC - ‍KNIGHT’S NEW DRUG SUBMISSION FOR NETILDEX HAS BEEN ACCEPTED FOR REVIEW BY HEALTH CANADA​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below